Objective. The purpose of this study was to examine the behavioural and cognitive eects of selegiline in a group of moderately behaviourally disturbed AD patients. Design. This was a 14-week randomized double-blind placebo-controlled study of selegiline (10 mg) and placebo. Setting. An outpatient
Selegiline treatment and the extent of degenerative changes in brain tissue of patients with Alzheimer's disease
β Scribed by I. Alafuzoff; S. Helisalmi; E. H. Heinonen; K. Reinikainen; M. Hallikainen; H. Soininen; K. Koivisto
- Publisher
- Springer
- Year
- 2000
- Tongue
- English
- Weight
- 108 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective To evaluate the effect of selegiline in the treatment of patients with Alzheimer's disease, in terms of cognitive performance, functional ability, emotional state (including behaviour and mood) and global response. ## Data Sources The Cochrane database of trials, Embase,
## Abstract Herpes simplex virus type 1 (HSVβ1) has been proposed as an environmental risk factor for sporadic Alzheimer's disease, although this issue is still in dispute. The involvement of HSVβ1 in the pathogenesis of familial Alzheimer's disease, the uncommon type of Alzheimer's disease, has no
## Abstract We developed a novel quantitative assay to test the hypothesis that defects in DNA cytosine methylation might be responsible for the brain chromatin abnormalities and transcriptional alterations observed in patients with Alzheimer's disease (AD). We found no significant difference in pe